J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 7 (1970), 169-171; DOI 10.1099/0022-1317-7-2-169
© 1970 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martos, L. M.
Right arrow Articles by Hampar, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martos, L. M.
Right arrow Articles by Hampar, B.
Agricola
Right arrow Articles by Martos, L. M.
Right arrow Articles by Hampar, B.

Preparation of Immune Rabbit Sera with Neutralizing Activity Against Human Cytomegalovirus and Varicella-Zoster Virus

Lidia M. Martos, D. V. Ablashi, R. V. Gilden and R. F. Sigüenza

Flow Laboratories, Inc. Rockville Maryland 20852

B. Hampar

Solid Tumor-Virus Section National Cancer Institute National Institutes of Health, Bethesda Maryland 20014

The classification of herpesviruses into two groups has been proposed (Melnick et al. 1964) based upon the tendency of the virus either to retain infectivity following liberation from host cells (Group A) or to remain intimately associated with host cells (Group B). In the case of primate herpesviruses, Group A strains include such viruses as herpes simplex of man and herpes-B and SA8 of monkeys, while Group B strains include cytomegalovirus of man and monkeys and varicella-zoster virus of man.

The preparation of immune sera in non-primates with neutralizing activity against human or simian Group A herpesviruses can be achieved readily, whereas the preparation of similar sera against Group B strains had proven difficult (Weller & Rowe, 1964). Immune sera have been prepared in sub-human primates which show neutralizing activity and fluorescent antibody activity against human cytomegalovirus and varicella-zoster virus respectively (Plummer & Benyesh-Melnick, 1964; Schmidt et al. 1965; Graham, Minamishima & Benyesh-Melnick, 1969), and immune sera with complement-fixing and fluorescent antibody activity against varicella-zoster virus have been prepared in guinea-pigs (Kissling, Casey & Palmer, 1968).

Received 10 November 1969; accepted 5 January 1970.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1970 by the Society for General Microbiology.